Piperazine Ferulate

阿魏酸哌嗪

Report date: 2022/03/18 13:32:58

Base Information

Drug NamePiperazine Ferulate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNephrotic Syndrome
Global Approved IndicationsNephrotic Syndrome
Approved Indications in ChinaNephrotic Syndrome
Original Approved Country/TerritoryMainland China
Original Approved Date1990/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSichuan Baoshengkang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Hengda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNephrotic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A